rs397516836
Variant summary
The NM_003000.3(SDHB):c.600G>T (p.Trp200Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene SDHB is a tumor suppressor gene (CancerMine: 12 TSG, 1 driver citations). The gene SDHB is a cancer driver gene (CancerMine: 12 TSG, 1 driver citations). The variant allele was found at a cumulative frequency of 0.00000682 (AC=11) in the gnomAD database across 1,613,960 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000241. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000212817: Functional studies demonstrated rapid and significant loss of W200C mutant SDHB protein compared to wildtype in a protein stability cell based assay (Yang C et al. FASEB J. 2012 Nov;26(11):4506-16)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.W200R: Likely_pathogenic (ClinVar VariationId 571856, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.W200G: Uncertain_significance (ClinVar VariationId 2942599, 1 star) The variant has been observed in cBioPortal in 4 samples across 3 studies and 2 cancer types; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.).
Frequency
Consequence
NM_003000.3 missense
Scores
Clinical Significance
Conservation
Publications
- Carney-Stratakis syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- gastrointestinal stromal tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- pheochromocytoma/paraganglioma syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- renal cell carcinomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- mitochondrial complex 2 deficiency, nuclear type 4Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- mitochondrial complex II deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_pathogenic. The variant received 8 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O1Established oncogenic variant | TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★) | ||
| O3Absent or very rare in population | Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000024 — very rare (O3 supporting [+1]) | ||
| O5Same location/impact as known oncogenic | Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Moderate: ≥10 same AA change, or strong functional domain signal; No cancerhotspots.org hit at this position; UniProt domain: 121 pathogenic, 13 benign (OR vs. background: 45.0).; ±8 AA neighbourhood: 13 pathogenic, 0 benign (OR vs. background: 135.0); Variant does not impact splicing — splice-hotspot path not applicable | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 0.44 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_003000.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SDHB | MANE Select | c.600G>T p.Trp200Cys | missense | Exon 6 of 8 | Prot: NP_002991.2 UniProt: | |
SDHB | c.546G>T p.Trp182Cys | missense | Exon 6 of 8 | Prot: NP_001394290.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SDHB | TSL:1MANE Select | c.600G>T p.Trp200Cys | missense | Exon 6 of 8 | Prot: ENSP00000364649.3 UniProt: | |
SDHB | c.645G>T p.Trp215Cys | missense | Exon 7 of 9 | Prot: ENSP00000519325.1 UniProt: | ||
SDHB | c.594G>T p.Trp198Cys | missense | Exon 6 of 8 | Prot: ENSP00000595680.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 5 sources | |||||
GnomAD3 genomes | AF: 0.00000657 | AC:1 | Hom:0 | AN:152212 | Cov:33 |
GnomAD4 exome | AF: 0.00000684 | AC:10 | Hom:0 | AN:1461748 | Cov:31 |
GnomAD4 genome | AF: 0.00000657 | AC:1 | Hom:0 | AN:152212 | Cov:33 |
TOPMed (Bravo) | AF: 0.0000113 | AC:3 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000640 | AC:4 | Hom:0 | AN:62496 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
Epi25 | 0.0000238 | 1 | 41958 | 0.0000150 | 1 | 66888 |
SCHEMA | 0.00000968 | 1 | 103272 | 0.00 | 0 | 184440 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 32 | |
AlphaMissense | Pathogenic | 1.0 | |
BayesDel_addAF | Pathogenic | 0.57 | D |
BayesDel_noAF | Pathogenic | 0.59 | |
CADD | Pathogenic | 33 | |
DANN | Uncertain | 0.99 | |
DEOGEN2 | Pathogenic | 0.92 | D |
Eigen | Pathogenic | 0.98 | |
Eigen_PC | Pathogenic | 0.91 | |
FATHMM_MKL | Pathogenic | 0.99 | D |
FuncVEP CTI | Pathogenic | 0.98 | |
GPN-Star LLR | N/A | -11 | |
GPN-Star score | N/A | 11 | |
LIST_S2 | Pathogenic | 1.0 | D |
M_CAP | Pathogenic | 0.81 | D |
MetaRNN | Pathogenic | 0.98 | D |
MetaSVM | Pathogenic | 1.1 | D |
Mutation Taster | N/A | 0/100 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 4.1 | H |
PhyloP100 | Uncertain | 7.1 | |
popEVE | Benign | -4.5 | |
PrimateAI | Pathogenic | 0.92 | D |
PROVEAN | Pathogenic | -12 | D |
REVEL | Pathogenic | 0.93 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.99 | |
VESM-3B | Benign | -13 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.